Presented by the Public Health Agency of Canada (PHAC), in partnership with the National Collaborating Centre for Infectious Diseases (NCCID)
English Session
Date and Time
Tuesday, September 24, 2024
11:30-1:00 pm Eastern Time (10:30 – 12:00 pm Central Time)
Description
This moderated, live webinar will discuss the current vaccine landscape in Canada and provide an overview of the latest recommendations from the National Advisory Committee on Immunization (NACI) for respiratory syncytial virus (RSV), seasonal influenza, and COVID-19 for the 2024-2025 respiratory virus season.
Learning objectives
At the end of this webinar, participants will be able to:
- Discuss RSV, Influenza, and COVID-19 in Canada.
- Discuss vaccines and/or monoclonal antibodies available for these respiratory viruses.
- Identify where to access NACI guidance, Canadian influenza antiviral guidelines, and other resources relevant to the prevention and treatment of respiratory illnesses during the 2024-2025 season.
This webinar will be delivered in English. Participants will have the opportunity to ask questions via the pre-webinar registration questionnaire, throughout the live webinar using a Q&A function, and during the question and answer (Q&A) period after the presentations. Post-event, a recording of the webinar in addition to a PDF of the slide deck will be posted on the NCCID website.
Access Instructions:
Access instructions for the live event will be emailed to all registrants.
Registration link: https://ca01web.zoom.us/webinar/register/WN_0U2zVLa_TwSASSE1YAuYIQ
Moderator:
Claudyne Chevrier, PhD, National Collaborating Centre for Infectious Diseases
Claudyne Chevrier is a Project Manager and the Stream leader for Tuberculosis at the National Collaborating Centre for Infectious Diseases. She is a medical anthropologist and public health researcher with a mixed training in global public health and critical social sciences.
Speakers
April Killikelly, PhD
April Killikelly is a Senior Scientific Project Coordinator with the NACI Secretariat at PHAC. She has worked on NACI statements for RSV, mpox (formerly monkeypox), COVID-19 and Ebola. She is the lead for RSV and Rabies for NACI Secretariat. Previously, she worked on CL-4/BL-4 containment laboratory coordination with the Canadian Food Inspection Agency. Her research background is in structure-based vaccine development for RSV, HIV, and S. aureus.
Angela Sinilaite, MPH, DrPH(c)
Angela Sinilaité is a senior technical advisor with the NACI Secretariat at PHAC. She supports the work of NACI, specifically for the development of national recommendations on the use of seasonal influenza vaccines in Canada.
Bryna Warshawsky, MDCM, MHSc, FRCPC:
Bryna Warshawsky is a Medical Advisor with the Centre for Immunization Surveillance and Programs at PHAC. She is a Public Health Physician by background and has worked in public health at the local, Ontario provincial, and national levels. She is a past member and Chair of NACI.
Accreditation Statement
Fall and Winter Respiratory Illnesses 2024-2025 is approved by the Canadian Institute of Public Health Inspectors (CIPHI), CIPHI members can enter Professional Development Hours (PDHs) if they participate in this webinar.